FIBREGA^TM  ( Fibronectin 0.5 mg/ml) Topical Spray 

Containing Plasma Native Fibronectin derived from Whole Blood for treatment of non healing wounds.

Depletion/Degradation of Fibronectin is the single penultimate reason for a normal wound to become chronic. In cases of Radiotherapy induced Skin reactions, Venous Ulcers, Diabetic Foot Ulcers, Pressure Ulcers and other non healing ulcers, the Fibronectin content at the wound site is the most consistently degraded even though its concentration in the plasma and blood of the same patient are normal.

As a result, despite multiple wound management therapies, the body tries to heal the wound but eventually fails to achieve the desired outcome due to lack of Fibronectin on site.

FIBREGA is a CDSCO approved biological blood product solution that allows exogenous application of readily bioactive plasma FIBRONECTIN directly to chronically non healing wounds.